Now I have enough calibration data. Let me write the final review.

## Summary

This paper tackles the important problem of model selection during self-supervised training of vision transformers in histopathology. It proposes a dual-metric selection procedure (Algorithm 1) that combines task-specific benchmark metrics (weighted F1, AJI) with task-agnostic rank-based metrics (RankMe, LiDAR, α-ReQ) to identify checkpoints that generalize better than the final training epoch. Nine DINOv1 models ranging from 21.6M to 922.3M parameters are trained on LUAD tissue, and the selected checkpoints are evaluated on five out-of-distribution benchmarks (BACH, CRC, PanNuke, MoNuSeg, MHIST) as well as two held-out clinical tasks (LUAD subtyping, EGFR classification). A central empirical finding is that SSL performance in histopathology often peaks mid-training and then degrades, contrary to the standard practice of training to convergence.

## Strengths

1. **Well-supported empirical observation that SSL models peak mid-training in histopathology.** Table 2 consistently shows that checkpoints selected by the procedure (whether classification-best, segmentation-best, or all-round) match or exceed final-epoch performance across all nine trained models. For example, ViT-S SMoE-32 drops from 0.60 to 0.56 on MoNuSeg between the selected checkpoint (epoch 131) and the final epoch, and most models show similar degradation across multiple benchmarks. This finding runs counter to the natural-image SSL convention that longer training improves generalization and is practically important for the histopathology community.

2. **Extensive empirical testbed with controlled architectural variation.** Nine models are trained spanning ViT-S/ViT-B, vanilla vs. SMoE (4–128 experts), single- vs. multi-magnification data, and parameter counts from 21.6M to 922.3M. This systematic variation (Table 1) strengthens confidence that the mid-training peaking pattern is not an artifact of a single configuration.

3. **Demonstration that small, tissue-specialized models can compete with large foundation models.** Models trained on ~10M images from a single tissue type (LUAD) achieve comparable or better instance segmentation performance than Virchow2 and UNI on PanNuke 20× (0.48 vs. 0.48) and MoNuSeg (0.60 vs. 0.58). This is an interesting observation about the specialization–generalization trade-off in histopathology.

4. **Concrete evidence that task-agnostic rank metrics alone are insufficient for non-linear tasks.** Figure 2 shows that segmentation performance (PanNuke AJI) degrades after a certain epoch while RankMe/LiDAR/α-ReQ continue to increase, empirically validating the paper's motivation for combining task-specific and task-agnostic signals rather than relying on rank metrics alone.

## Weaknesses

### Major

1. **No ablation isolating the contribution of task-agnostic metrics.** This is the most significant weakness. The paper's core claim is that combining task-specific *and* task-agnostic metrics improves selection, but Algorithm 1 is never compared against a version that uses *only* task-specific metrics (e.g., simply picking the epoch with the highest average normalized benchmark score across all epochs). Algorithm 1 uses task-agnostic metrics only as a filter (steps 3–4 narrow candidate epochs), then selects based purely on task-specific metrics (steps 5–6). Without ablating this filtering step, it is impossible to know whether the task-agnostic metrics improve selection over the task-specific-only baseline, add nothing, or even hurt. The held-out analysis in Section 5.3 (Figure 4) compares only the three selection variants (classification-best, segmentation-best, all-round) *against each other*, without including either the final-epoch checkpoint or a task-specific-only baseline. This gap prevents the paper from supporting its central claim about the dual-metric combination.

2. **No variance or uncertainty reporting.** Table 2 reports benchmark scores to two decimal places without standard deviations, confidence intervals, or any measure of uncertainty. For comparisons such as ViT-S SMoE-32 achieving 0.60 on MoNuSeg vs. Virchow2's 0.58, the reader cannot assess whether this difference is meaningful. Similarly, Figure 4 concatenates predictions across 10 train/test splits to produce a single AUC estimate rather than reporting the mean and variance across splits (the standard practice for AUC evaluation). Without error bars, apparent differences between checkpoint types (e.g., in Figure 4a) could easily be within noise.

3. **Algorithm 1's "relative improvement" step is misnamed and underspecified.** Step 5 of Algorithm 1 computes r_k = sum of normalized task-specific metrics — this is not a *relative* improvement over anything, but an absolute sum. The accompanying text (Section 5.1) says it "maximizes the relative improvement over all tasks" without defining "relative" to what baseline. The normalization uses MinMax over epochs, which is sensitive to single-epoch outliers and makes results non-comparable across models. These clarity issues make the method harder to reproduce and assess than it should be.

### Minor

1. **Held-out tasks share the same tissue type as pretraining.** The two held-out tasks (LUAD subtyping, EGFR classification) are from the same organ (lung) as the pretraining data. This limits the strength of claims about generalization — the paper cannot distinguish between "the selection method generalizes" and "any LUAD-trained model works on LUAD-related tasks." Including a held-out task from a different tissue type would strengthen the claims, though the paper acknowledges its single-tissue scope.

2. **Foundation model comparison is not a clean validation of the method.** The observation that small specialized models match foundation models on some benchmarks is interesting but confounded by multiple factors: the foundation models are tested only at their final checkpoints (while the paper's own finding is that later checkpoints are often worse), they are pan-cancer rather than tissue-specialized, and differences are small. This comparison is presented more as an observation than a formal evaluation, so it is not a fatal issue, but the paper's framing (Abstract: "achieve instance segmentation performance comparable to state-of-the-art models trained on much larger datasets") overstates what the evidence supports.

### Trivial

- The gray highlighting in Table 2 is described as "cases where the final epoch value result is similar to the best, or exceeds the best task-specific metric among all checkpoints selected for a specific encoder" — the criterion for "similar" is not defined.
- In Algorithm 1, the notation for normalization (MinMaxNormalize) and the argmax/argmax computations could be clarified with explicit formulas.
- Figure 4 uses labels e_s^1, e_s^2, e_s^3 which are explained only in the caption.

### Nice-to-Haves

- Comparing against a baseline that selects the checkpoint using only task-specific metrics (without task-agnostic filtering) would directly isolate the contribution of the dual-metric aspect.
- Reporting standard deviations or confidence intervals for the benchmark results (Table 2) and mean±std over splits for Figure 4.
- A discussion of the computational overhead of computing rank estimation metrics for every saved checkpoint on a large pre-training test set.

## Removed Points

- **"The evaluation is circular / tautological"** — The harsh critic claimed Table 2 is logically invalid because the same benchmarks used in Algorithm 1 appear in the results. This is not correct. Table 2 compares selected checkpoints against the **final checkpoint**, which was not produced by the selection procedure and is a meaningful baseline. The comparison shows that the selected checkpoint beats naive training-to-convergence, which is a non-tautological result. However, the critic's sub-point about missing ablation for task-agnostic metrics is retained above.

- **"No comparison to final checkpoint"** — The critic claimed the held-out analysis (Section 5.3) does not compare against the final checkpoint. This is correct for Figure 4 specifically, but the overall paper (Table 2) does compare against the final checkpoint. The held-out analysis missing the final checkpoint is retained as a concern within Major #1.

- **"Missing related works"** — Removed per instructions (cannot verify existence of missing citations).

- **General formatting/style nitpicks** — Removed per instructions.

- **"Rationale for SMoE is not connected to histopathology"** — The paper explains SMoE as an architectural variation to increase capacity without sacrificing throughput (Section 4), which is a reasonable rationale for studying model capacity variation.

- **Strawman about overclaiming** — The critic says comparison to foundation models "says nothing about whether the dual-metric approach improves selection." The paper presents this comparison as an observation about model performance, not as validation of the selection method.

## Novel Insights

None beyond the paper's own contributions. The reviewers' analyses do not surface a pattern or connection the paper itself does not already identify.

## Suggestions

1. **Add a proper ablation:** Compare Algorithm 1 against (a) selecting the epoch with the highest average normalized task-specific metric across all epochs (no task-agnostic filtering), (b) selecting the epoch with the highest average normalized task-agnostic metric, and (c) the final epoch. Report these on a held-out benchmark (not used in selection) to determine whether the dual-metric filtering adds value.

2. **Report uncertainty:** Add standard deviations or confidence intervals for all benchmark results, and report mean±std across splits for the AUC values in Figure 4.

3. **Clarify Algorithm 1:** Rename "relative improvement" to something more accurate (e.g., "cumulative normalized score"), define the MinMax normalization explicitly, and discuss sensitivity to outlier epochs.

4. **Include the final checkpoint in Figure 4** to establish a non-selection baseline for the held-out tasks.

5. **Reframe the foundation model comparison** as an observation about specialization vs. generalization rather than evidence validating the selection method. This would better align the claims with the evidence.

## Score and Decision

Round 1 bracket: Based on comparisons, the paper sits between the weak anchors (scores 2–3.5: clearly inferior papers) and the strong anchors (scores 7.5+: top-tier ICLR papers with rigorous validation). The initial bracket is roughly **4–6**.

Round 2 narrowing: Compared against mid-range anchors:
- **UDA metrics paper** (avg 5.0, withdrawn): Similar contribution type (evaluation/selection method), similar weakness (missing ablations). The current paper has more extensive experiments (9 trained models) but the same core evaluation gap. **Comparable.**
- **Scaling Channel-Invariant SSL** (avg 4.4, reject): More rigorous experiments but less novelty. Current paper is **slightly stronger.**
- **Screener** (avg 5.33, reject): Comparable quality. Current paper's empirical base is broader, but Screener has cleaner evaluation. **Comparable.**
- **VLSA** (avg 5.67, accept poster): Accepted paper with more technical novelty but similar evaluation limitations. Current paper is **slightly weaker.**
- **SSOLE** (avg 6.75, accept poster): Significantly stronger paper with theoretical grounding and cleaner experiments. **Weaker than this anchor.**

Final calibration: The paper makes a genuine empirical contribution (the mid-training peaking finding in histopathology SSL) and has extensive experimental breadth. However, the core methodological claim (dual-metric selection is beneficial) is not properly validated due to the missing ablation, and the lack of variance reporting further weakens the evidence. This places the paper at the boundary — below the validation standard for acceptance but above a simple reject.

**Score: 5.0** — Marginally below the acceptance threshold. The paper's empirical observations are valuable, but the evaluation of the proposed method is incomplete in a way that prevents the central claim from being supported. A substantially revised evaluation with proper ablations and uncertainty reporting could make this a solid contribution.

| Anchor Paper | Path | Avg Score | Round | Comparison |
|---|---|---|---|---|
| Masked Mamba | V9UsZBbTvZ | 3.00 | 1 | Weaker: less extensive experiments, less clear contribution |
| Texture Transformer | MrOefpTvev | 2.33 | 1 | Weaker: poorly motivated, unclear methodology |
| Mamba-HMIL | 0yVP49SDg0 | 3.25 | 1 | Weaker: limited novelty |
| Fingerprint SSL | hH5HK4hsLY | 2.33 | 1 | Weaker: narrower scope |
| UDA Metrics | j9dDXNffBz | 5.00 | 1 | Comparable: similar contribution type and evaluation gaps |
| Self-SL vs Semi-SL | nnYsWoe1ST | 4.00 | 1 | Slightly weaker: less extensive empirical work |
| Depth-Guided SSL | uBpSkFGVQU | 3.67 | 1 | Weaker: less convincing results |
| SSOLE | zBgiCWCxJB | 6.75 | 1 | Stronger: has theoretical analysis, cleaner experiments |
| ViT Registers | 2dnO3LLiJ1 | 8.00 | 1 | Stronger: top-tier paper, rigorous evaluation |
| CrIBo | 3M0GXoUEzP | 8.00 | 1 | Stronger: top-tier paper |
| Never Train from Scratch | PdaPky8MUn | 8.00 | 1 | Stronger: top-tier paper |
| Hierarchical Segmentation | IRcv4yFX6z | 8.00 | 1 | Stronger: top-tier paper |
| Scaling Channel-Invariant SSL | aefNwingnS | 4.40 | 2 | Slightly weaker: less novelty |
| Screener | K4JHTZ13G3 | 5.33 | 2 | Comparable: similar quality and issues |
| Unifying Supervisions | zi3MEZRCqd | 4.60 | 2 | Slightly weaker |
| VLSA | trj2Jq8riA | 5.67 | 2 | Slightly stronger: more novelty, accepted |
| BEV Uncertainty | k3y0oyK7sn | 5.40 | 2 | Comparable |
| SE(2) Invariants | jOVfFAxBf6 | 5.75 | 2 | Different type of work |
| CUS3D | kRdcwzEL5J | 5.25 | 2 | Comparable |
| Multi-Frequency Features | 5JWAOLBxwp | 5.80 | 2 | Stronger: accepted poster |

MY FINAL SCORE: <score>5.0</score>
MY FINAL DECISION: <decision>Reject</decision>